Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Basso

Showing results (141-150 of 379) with videos related to

Pageof 38
Sort By:
Cancer Research|June 5, 2007
Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastomaLizzia Raffaghello, Paolo Nozza, Fabio Morandi, et al.
Cytometry. Part B, Clinical Cytometry|March 5, 2010
Modulation of antigen expression in B-cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: evidence for a drug-induced regulatory phenomenon. Results of the AIEOP-BFM-ALL-FLOW-MRD-Study GroupMichael N Dworzak, Giuseppe Gaipa, Angela Schumich, et al.
European Journal of Medicinal Chemistry|May 27, 2014
Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Cell Death & Disease|August 3, 2018
Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axisMicol Silic-Benussi, Gloria Scattolin, Ilaria Cavallari, et al.
Biochemical Pharmacology|July 15, 2018
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cellsElena Mariotto, Roberta Bortolozzi, Ilaria Volpin, et al.
Haematologica|September 2, 2011
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian studyMaddalena Paganin, Martina Pigazzi, Silvia Bresolin, et al.
Pharmacogenomics|December 7, 2017
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocolFrancesco Ceppi, Vincent Gagné, Laurance Douyon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhoodLara Mussolin, Marta Pillon, Valentino Conter, et al.
Blood|September 11, 2008
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapyMichael N Dworzak, Angela Schumich, Dieter Printz, et al.
European Journal of Medicinal Chemistry|November 9, 2016
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agentsDavide Carta, Roberta Bortolozzi, Mattia Sturlese, et al.
Pageof 38

Showing results (141-150 of 379) with videos related to

Sort By:
Pageof 38
Cancer Research|June 5, 2007
Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastomaLizzia Raffaghello, Paolo Nozza, Fabio Morandi, et al.
Cytometry. Part B, Clinical Cytometry|March 5, 2010
Modulation of antigen expression in B-cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: evidence for a drug-induced regulatory phenomenon. Results of the AIEOP-BFM-ALL-FLOW-MRD-Study GroupMichael N Dworzak, Giuseppe Gaipa, Angela Schumich, et al.
European Journal of Medicinal Chemistry|May 27, 2014
Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Cell Death & Disease|August 3, 2018
Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axisMicol Silic-Benussi, Gloria Scattolin, Ilaria Cavallari, et al.
Biochemical Pharmacology|July 15, 2018
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cellsElena Mariotto, Roberta Bortolozzi, Ilaria Volpin, et al.
Haematologica|September 2, 2011
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian studyMaddalena Paganin, Martina Pigazzi, Silvia Bresolin, et al.
Pharmacogenomics|December 7, 2017
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocolFrancesco Ceppi, Vincent Gagné, Laurance Douyon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhoodLara Mussolin, Marta Pillon, Valentino Conter, et al.
Blood|September 11, 2008
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapyMichael N Dworzak, Angela Schumich, Dieter Printz, et al.
European Journal of Medicinal Chemistry|November 9, 2016
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agentsDavide Carta, Roberta Bortolozzi, Mattia Sturlese, et al.
Pageof 38